| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From the Department of Pharmacology (D.V., H.S.T., M.D., G.E.M., J.J.) and Department of Microbiology and Immunology (S.M.T.), SUNY Upstate Medical University, Syracuse, NY, and Department of Biology (C.W.L.), University of Pennsylvania, Philadelphia, Pa.
Correspondence to José Jalife, MD, SUNY Upstate Medical University, 766 Irving Ave, Syracuse, NY 13210. E-mail jalifej{at}upstate.edu
Abstract
AbstractConnexin43 (Cx43) is the principal connexin isoform in the mouse ventricle, where it is thought to provide electrical coupling between cells. Knocking out this gene results in anatomic malformations that nevertheless allow for survival through early neonatal life. We examined electrical wave propagation in the left (LV) and right (RV) ventricles of isolated Cx43 null mutated (Cx43-/-), heterozygous (Cx43+/-), and wild-type (WT) embryos using high-resolution mapping of voltage-sensitive dye fluorescence. Consistent with the compensating presence of the other connexins, no reduction in propagation velocity was seen in Cx43-/- ventricles at postcoital day (dpc) 12.5 compared with WT or Cx43+/- ventricles. A gross reduction in conduction velocity was seen in the RV at 15.5 dpc (in cm/second, mean [1 SE confidence interval], WT 9.9 [8.7 to 11.2], Cx43+/- 9.9 [9.0 to 10.9], and Cx43-/- 2.2 [1.8 to 2.7; P<0.005]) and in both ventricles at 17.5 dpc (in RV, WT 8.4 [7.6 to 9.3], Cx43+/- 8.7 [8.1 to 9.3], and Cx43-/- 1.1 [0.1 to 1.3; P<0.005]; in LV, WT 10.1 [9.4 to 10.7], Cx43+/- 8.3 [7.8 to 8.9], and Cx43-/- 1.7 [1.3 to 2.1; P<0.005]) corresponding with the downregulation of Cx40. Cx40 and Cx45 mRNAs were detectable in ventricular homogenates even at 17.5 dpc, probably accounting for the residual conduction function. Neonatal knockout hearts were arrhythmic in vivo as well as ex vivo. This study demonstrates the contribution of Cx43 to the electrical function of the developing mouse heart and the essential role of this gene in maintaining heart rhythm in postnatal life.
Key Words: connexin development arrhythmia electrophysiology knockout
Gap junction channels (connexins) are specialized membrane structures that allow for direct communication between neighboring cells.1 Although previous work documented the spatial and temporal patterns of expression of different connexin isoforms,2 3 4 5 6 7 8 9 10 11 12 the functional correlates of this diversity of connexins are poorly understood. Analysis of mice with null mutations has shed some light on the function of specific connexin genes and their products.13 14 15 16 17 Connexin43 (Cx43) has widespread spatial distribution from the 2-cell stage through postnatal life in the mouse.18 However, the null mutation of the Cx43 gene results in anatomic malformations that are incompatible with postnatal life.13 The cardiac phenotype of the Cx43 null mutation includes delayed looping,19 intertrabecular pouching of the right ventricular cavity, and right ventricular outflow tract obstruction.13 The presence of other connexins, notably Cx40,19 may explain why the heart functions through gestation. However, it is not known at what stage Cx43 becomes the predominant gap junction involved in electrical impulse propagation.
Thus, the Cx43-/- embryo presents a unique system in which to study the role of this protein in electrical conduction in the developing heart as it replaces other connexins and becomes the predominant cardiac isoform during late gestation.20 Because of the small size and fragility of the embryonic heart, traditional techniques to study electrical activity such as multiple extracellular electrodes or microelectrode mapping may present great technical difficulties. High-resolution optical mapping of voltage-dependent changes in cardiac tissue21 22 23 has previously been used in the adult mouse,24 25 the embryonic chick,26 27 and other rodent hearts,26 as well as cellular preparations.28 29 This study uses optical mapping to explore the role of Cx43 in cardiac impulse propagation during the embryonic development and the early postnatal life in the mouse.
Materials and Methods
Heart Preparations
All animal care protocols conformed to institutional
and NIH guidelines. The mouse colony was founded by a breeding pair
(129Sv/C57BL6/CD1 strain) heterozygous for the Cx43 knockout mutation.
Pregnant dams were euthanized at 12.5, 15.5, and 17.5 days postcoitum
(dpc) to obtain embryonic hearts. While embryonic preparations were
superfused, hearts of 5 days postpartum (dpp) mice were also perfused
via aortic cannulation. No pharmacological or mechanical
motion-reduction techniques were used during any of the experimental
protocols. Voltage-sensitive dye fluorescence from stained
hearts was mapped optically on an upright microscope equipped with a
charge-coupled device camera (Dalsa Inc, model CA-D1 128T) as discussed
in detail
previously.24 30
Pacing Protocol for Measurement of
Conduction Velocity
Hearts at 12.5 and 15.5 dpc as well as those at 5 dpp
were allowed to beat in sinus rhythm, and optical mapping records
were obtained to measure the heart rate. A suction glass electrode with
an outer diameter of 25 to 100 µm and a fire-polished tip was used to
deliver unipolar pacing stimuli to the ventricles. The left (LV) and
right (RV) ventricles were separately paced at a basic cycle length
(BCL) of 300 ms at 12.5 and 15.5 dpc, 200 ms at 17.5 dpc, and 100 ms at
5 dpp using 4-ms stimuli at 1.5 times diastolic threshold.
Activity during pacing and during arrhythmias, if any, was
recorded for 4 seconds. Pacing was attempted in arrhythmic
Cx43-/- hearts at 5 dpp with unipolar as
well as bipolar silver/silver chloride electrodes with diameters
ranging from 0.2 to 1 mm. Optical movies of paced activity were
signal-averaged as described
previously.24 30 31
The conduction velocity in the slowest direction was quantified for the
RV and LV for all the time points studied.
RNase Protection Assay
Ventricles of hearts at 17.5 dpc used to extract
total cellular RNA were dissected in ice-cold Tyrodes solution and
immediately homogenized in Triazol reagent (MRC Inc), and
total tissue RNA was extracted according to the manufacturers
protocol. Antisense probes were designed to recognize regions within
the coding sequences of Cx40, Cx43, and Cx45. A probe for the mouse
housekeeping gene cyclophilin was used as a control for loading. RNase
protection assay (RPA) was carried out using the Riboquant RPA
kit (Pharmingen). At 17.5 days, the cyclophilin signal showed no
genotype-dependent changes (in million counts per 15 hours,
wild type [WT] 3.55±0.87 [n=4],
Cx43+/-
3.47±0.38 [n=8], and Cx43-/-
3.62±0.68 [n=3]). Connexin RPA signals were quantified as a
percentage of cyclophilin signal.
Microelectrode Recordings
Recordings were obtained using 15- to 30-M
microelectrodes filled with 3 mol/L KCl solution. The signals were
appropriately conditioned and sampled at 15 to 20 kHz. The resting
membrane potential, action potential amplitude, and maximum upstroke
velocity (dV/dtmax) were analyzed in
15.5-dpc embryos.
Electrocardiography in
Conscious Mice
A custom-built chamber with four silver-silver
chloride footpads embedded in the floor was used to record ECGs in
conscious mice at 5 dpp. The pads were wetted with ECG electrode jelly,
and the mice were placed in the chamber such that each foot of the
mouse made contact with a separate electrode. No physical restraint is
required at this age. Signals were amplified and low-pass filtered with
a differential amplifier (CyberAmp 380, Axon
Instruments), digitized (Digidata 1200) at 5 kHz, and
stored for offline analysis.
Statistical Analysis
All values are reported as confidence intervals of
mean±SE. Differences were considered significant at the
P<0.05 level using
ANOVA.
An expanded Materials and Methods section can be found in the online data supplement available at http://www.circresaha.org.
Results
Viability of the Preparation
Heart rates at sinus rhythm were recorded for
superfused embryonic hearts at 12.5 and 15.5 dpc, as well as perfused
5-day postnatal hearts. The heart rates were comparable for all
genotypes (in bpm, for 12.5 dpc, WT 117.6±13.4 [n=10],
Cx43+/-
118.5±8.3 [n=24], and Cx43-/-
99.9±10.7 [n=10]; for 15.5 dpc, WT 172.5±22.1 [n=15],
Cx43+/-
154.8±17.6 [n=13], and Cx43-/-
140.7±19.3 [n=14]; and for 5-day postnatal, WT 444.5±16.1 [n=
14], Cx43+/-
436.5±12.1 [n=15], and Cx43-/- all
arrhythmic [n=4]). The atria of all 17.5-dpc embryonic hearts were
crushed to make them asystolic. The above cycle lengths are
comparable with those recorded previously for in
vivo32 33 and
superfused embryonic
hearts34 as well as for
perfused postnatal
hearts.24 31 35
Optical Mapping of Paced Electrical
Activity
By 12.5 dpc, the muscular septum of the ventricle grows
apace and is nearly fully
formed.36 An anatomic
deformity in the angle of the bending of the heart tube is already
apparent in the Cx43-/- heart by this
time point.19 At this stage,
both Cx43 and Cx40 are strongly expressed throughout the WT
ventricles.4 The velocities
in the direction of slowest propagation during pacing of the RV and LV
at a BCL of 300 ms are tabulated in
Table 1
. The RV conduction velocities were reduced compared
with the LV in all genotypes
(P<0.005). However, no
significant genotype-related change in velocity was found in
either ventricle.
|
At 16 dpc, the chamber formation in the heart is essentially
complete.36 Cx40 is no
longer detected in the RV, although it is detected in the LV
trabeculated
myocardium.19 As
seen in
Table 1
, no LV conduction velocity differences are seen
between genotypes during ventricular pacing at the
BCL of 300 ms in 15.5-dpc hearts. However, RV conduction is grossly
reduced in the Cx43-/- hearts compared
with the other genotypes
(P<0.005). Thus, it appears
that the presence of Cx40 in the trabeculated
myocardium of the LV is adequate to maintain propagation
within the whole wall. The voltage-dependent fluorescence
signal is expected to originate throughout the depth of the
ventricular
wall37 ; the optical mapping
records may not reflect isolated slow conduction within the compact
layers of the LV myocardium, if it occurs.
By day 18, Cx40 is downregulated throughout the left and
right ventricular
myocardium.19
The effect of this downregulation of all connexins other than Cx43 in
the entire ventricular myocardium is seen as an
extreme reduction in the conduction velocity in both ventricles of the
Cx43-/- heart at this stage
(Table 1
, P<0.005).
Both the LV and the RV show similar conduction times in WT and
Cx43+/- hearts.
Videos of representative activation sequences in the LV
and RV at all embryonic points can be found in an online data
supplement available at http://www.circresaha.org.
RV and LV propagation was studied only in WT and
Cx43+/- mice at
5 dpp. As seen in
Table 1
, RV velocities are significantly different from
those in the LV (P<0.05),
although there is no significant genotype-dependent difference.
At this stage, a small number of Cx43-/-
knockout mice remain alive. However, none of the
Cx43-/- hearts could be paced for the
measurement of conduction velocity.
Arrhythmias in
Cx43-/- Hearts
No arrhythmias were observed in any of the
embryonic hearts at 12.5 or 15.5 dpc. At 17.5 dpc, none of the 20 WT
hearts and one of the 35
Cx43+/- hearts
showed ventricular arrhythmia at some point during
the protocol. Of the 20 Cx43-/- hearts
studied, 10 underwent ventricular arrhythmias
throughout the periods of observation and could not be paced. Of the
remaining hearts, eight showed arrhythmia at some point during
the protocol, often induced by the pacing, whereas two hearts showed no
arrhythmias (P<0.005).
An example of the activation pattern during spontaneous
arrhythmia showing a transient reentrant circuit initiated by
ectopic activity that degenerates into a polymorphic
tachycardia has been presented in an online data
supplement available at http://www.circresaha.org.
All four of the Cx43-/-
hearts mapped at 5 dpp were arrhythmic. One heart showed
polymorphic activity, whereas three hearts showed monomorphic
activation patterns. The activation map during this polymorphic
tachycardia is shown in
Figure 1
. The reentrant activity lasted for three rotations
(thick white arrow), after which the rotor drifted out of the field of
view. A complex pattern of breakthrough (asterisk) and block and
collision (thin arrows) was observed in the regions adjacent to the
reentrant circuit, suggesting a 3-dimensional component to the reentry.
The trace below is the pseudo-ECG, which is the summary of the whole
movie in time.38 The
polymorphic pattern is apparent in the trace. Two of the
monomorphic patterns involved waves entering the field of view from one
side, whereas one showed a diffuse breakthrough within the field of
view. Although focal activity cannot be excluded, slow conduction in
this phenotype makes it probable that anatomic or anchored
3-dimensional reentry may be responsible for these
arrhythmias.
|
Electrocardiography in
5-Day Postnatal Mice
We studied the electrocardiographic phenotype
of the Cx43-/- mouse to determine
whether the arrhythmias observed above were only an artifact of
Langendorff perfusion. The ECGs were obtained in the conscious state to
avoid the nonspecific and hypothermic effects of
anesthesia. In
Figure 2
, the heart rates recorded in WT mice (heart
rate 510±20 bpm and PR interval 44.9±2.1 ms [n=14], trace A) and
Cx43+/- mice
(heart rate 495±16 bpm, PR interval 45.1±1.2 ms [n=21], trace B)
are comparable with those previously reported in conscious neonatal
mice.39 Although none of the
WT or Cx43+/-
hearts studied showed any arrhythmias, all 5
Cx43-/- mice showed ECG abnormalities.
Individual examples are shown in
Figure 2
, traces C through E. Although the atrial activation
rate was not significantly reduced compared with the other
genotypes (476±16 bpm [n=4]), one animal had second-degree
heart block (trace C and inset), three had third-degree block (trace
D), and one had ventricular arrhythmia (trace E).
Thus, Cx43-/- mice have cardiac rhythm
abnormalities in the conscious state.
|
Microelectrode Recordings in 15.5-dpc
Hearts
The velocity of conduction depends on both the axial
resistance for current flow and the excitatory currents available for
depolarization. We excluded genotype-specific reduction in the
excitatory currents by recording the upstroke of the action
potential in hearts at 15.5 dpc.
Figure 3
shows representative action
potential upstrokes and dV/dt signals from the RV and LV of the three
genotypes. Faster upstroke velocities can be seen in
Cx43-/- ventricles compared with WT and
Cx43+/-
ventricles.
Table 2
summarizes the electrophysiologic properties of
three WT, 5
Cx43+/-, and
three Cx43-/- hearts. Although there is
no significant difference between the resting membrane potential or the
action potential amplitude between genotypes, the
dV/dtmax is higher in the
Cx43-/- mouse than in the WT and
Cx43+/- hearts.
The observation that the dV/dtmax is not reduced
in the Cx43-/- embryos suggests that the
slow propagation seen at this time point is not a result of a
concurrent reduction in excitatory currents. This is consistent
with the findings of Johnson et
al,40 who studied sodium
currents in Cx43-/- animals at term.
However, that study found no increase in the upstroke velocity in
isolated myocytes.40 The
paradoxic increase in the upstroke velocity gives credence to a
computational prediction of Rudy and
Quan41 that in the presence
of unchanged excitatory currents, the higher input resistance of poorly
coupled cells must result in higher upstroke velocities. Note that only
RV and not LV conduction velocity was found to be reduced in the
Cx43-/- heart at 15.5 dpc. However, this
conduction function may be sustained by the trabeculated
myocardium, which expresses
Cx40.19 The microelectrode
recordings are superficial and likely to sample only the
compact layer of the ventricular myocardium, in
which no Cx40 or Cx43 is found in the
Cx43-/-
heart.19 This may explain
the higher dV/dtmax observed in microelectrode
recordings from both ventricles at this
stage.
|
|
Presence of Other Connexins in the Late
Cx43-/- Embryo
By day 18, little or no Cx40 has been demonstrated by
immunohistochemistry and in situ hybridization of mRNA, and little or
no Cx45 has been demonstrated by in situ
hybridization.19 To
determine what connexin is responsible for the residual slow
conduction, we performed RPAs for Cx40, Cx43, and Cx45 as a sensitive
measure of RNA message in 17.5-dpc ventricles. As seen in
Figure 4
, signals for Cx43, Cx40 and Cx45 are all detected
in WT and
Cx43+/- hearts
in quantities greater than that found in whole
Cx43+/-
embryonic RNA. Cx43 signal as a percentage of the cyclophilin signal is
reduced in the
Cx43+/- heart
(in percentage of cyclophilin signal, WT 44.8±0.8 [n=4] and
Cx43+/-
23.0±0.8 [n=8],
P=10-8).
Cx40 and Cx45 bands are also found in
Cx43-/- hearts. There is no
genotype-specific difference in the expression of Cx40 and Cx45
at this stage (WT n=4,
Cx43+/- n=6,
and Cx43-/- n=3). Thus, Cx40 and Cx45
are present in the embryonic ventricle at this stage and are
probably responsible for the residual conduction function during late
gestation in Cx43-/-
embryos.
|
Discussion
Connexins and Conduction in Embryonic
Life
This study is the first to demonstrate developmental
changes in ventricular conduction velocity in the LV and RV
through fetal life and birth in WT and Cx43 knockout mice. The most
important result of this study is the demonstration that the lack of
Cx43 causes slowing of cardiac propagation late in the embryonic
development of the Cx43-/- mouse. The
important role played by connexins in cell differentiation and
development is evidenced by their early and patterned expression in
embryonic
life.4 18 42
Perturbations in the expression of the cardiac connexins lead to a
spectrum of malformations greatly differing in severity. Although the
nonexpression of Cx45 causes early embryonic
death,16 17 no
reduction in viability is observed with the nonexpression of
Cx40.14 15 Mice
null mutated for the Cx43 gene show survival until birth, when they die
of cyanosis caused by right ventricular outflow tract
obstruction.13 Targeted
replacement of the gene for Cx43 by the cardiac connexin Cx40 as well
as the noncardiac gene Cx32 results in viable mice that survive into
adult life, indicating that some of the vital functions of connexins
are shared between these different
isoforms.43 Thus, the
developmental pattern of the expression of various connexins may be
related to performance of their shared and unique functions
during the different stages of embryogenesis. Cx45 has been detected in
the embryonic heart at 8.5
dpc.42 It is downregulated
in the ventricular myocardium by 12 dpc, after
which very small quantities are detected except in the outflow
tract.7 42 Cx40
and Cx43 appear in the ventricles at 10.5 dpc and continue to increase
until 14.5 dpc.3 4
Between this point and 18 dpc, Cx40 ceases to be detected by
immunohistochemistry and in situ hybridization of
mRNA.19 This downregulation
first takes place in the RV, whereas the left ventricular
trabecular myocardium still expresses
Cx40.19 The results
presented above show that the propagation velocity of
electrical impulses in Cx43-/- embryos
is reduced in the same sequence as the downregulation of Cx40. Because
optical mapping at this stage involves recording throughout the
depth of the ventricular
wall,37 and given that
propagation during ventricular pacing involves electrotonic
coupling throughout the
wall,44 the rapid
propagation in the Cx43-/- LV at 15.5
dpc may be explained by the presence of Cx40 coupling deeper myocardial
layers. This finding argues that conduction of electrical activation
waves in the ventricle is a shared function of Cx43 and Cx40. The gross
reduction in conduction velocity at 17.5 dpc in the
Cx43-/- mouse also highlights the fact
that Cx43 is largely responsible for the conduction of electrical
impulses in the ventricles during late embryonic life. We may only
speculate that the 2.5- to 3-fold increase in conduction velocity seen
in WT and
Cx43+/- mice
between embryonic life and 5 dpp may occur as a result of an increase
in Cx43 expression,20 other
ionic
channels,45 46 47
or mechanical changes associated with
circulation48 that occur
during this period.
Conduction in the
Cx43+/-
Heart
There have been conflicting reports about reductions in
conduction velocity in the
Cx43+/- mouse
compared with
WT.49 50 In this
study no significant difference was found in the conduction velocity in
either ventricle. Indeed, previously reported differences in conduction
velocities between
Cx43+/- and WT
were less dramatic at birth than during adult
life.49 Computational
studies51 52 and
a recent experimental
study48 suggest that
profound changes are required in the expression of gap junction
channels to produce relatively modest changes in conduction
velocity.
Residual Conduction in the
Cx43-/- Embryo
Cx40 has not been identified either by in situ
hybridization of mRNA or by immunohistochemistry in 18-dpc
mice,19 whereas little if
any Cx45 has been detected by in situ hybridization at this stage
either in WT,
Cx43+/-, or
Cx43-/-
mice.19 Our results in
pooled whole-ventricular RNA at this stage suggest that
small quantities of Cx40 and Cx45 persist in the ventricles and may
account for the residual conduction function seen in
Cx43-/- embryos at this
stage.
Relationship Between Excitatory Currents
and Coupling
The excitatory current that travels from cell to cell
is provided by inward ionic flow through sodium and calcium channels.
It has been shown that reduction in inward currents can lead to a
slowing in propagation velocity before conduction block
ensues.24 41 52
However, this slowing of propagation is not as profound as that which
can be achieved by a reduction of
coupling.41 52 A
key difference between the two mechanisms is that the
dV/dtmax is reduced with a primary deficit in
excitatory currents, whereas it has a biphasic relationship with the
degree of coupling. The first phase of reduction in coupling is
associated with an increase in the dV/dtmax
caused by the higher-input resistance of the cell, whereas extreme
degrees of uncoupling close to the onset of block are associated with a
decrease in the dV/dtmax. Our measurements in
the 15.5-dpc embryo show that the knockout heart has a high
dV/dtmax, indicating that a reduction in
excitatory currents is not the primary cause of slow propagation. These
data are in agreement with previously published results showing that
the sodium current in isolated ventricular knockout
myocytes is not reduced compared with
WT.40 Indeed, the higher
dV/dtmax suggests that reduced coupling is the
primary cause of the reduction in conduction velocity. It is possible
that the higher dV/dtmax observed in the LV at
this stage is due to the poor coupling of epicardial cells, although
well-coupled subendocardial cells maintain conduction function as
discussed above.
Arrhythmias in
Cx43-/- Mice
Arrhythmias were commonly observed in
Cx43-/- mice at 17.5 dpc, and as a rule
after birth. The arrhythmias in 5-dpp mice were observed in the
conscious state as well as ex vivo. Although the triggers for
spontaneous arrhythmias may be focal, slow conduction likely
makes sustained reentrant arrhythmias possible. It is possible
that the hypoxia suffered by the mouse during postnatal life
may be responsible for the arrhythmias. However, the embryonic
circulation largely bypasses the pulmonary bed and receives
oxygenation at the placenta. It is not expected that
the late embryonic heart is hypoxic. The observation of spontaneous as
well as pacing-induced arrhythmias at 17.5 dpc suggests that
reduction in conduction velocity makes the heart an arrhythmogenic
substrate. This strengthens the conjecture that slow propagation due to
the absence of Cx43 and the hypoxia caused by the outflow tract
malformation are probable causes of death in the
Cx43-/-
heart.
Acknowledgments
This work was supported in part by NIH Grants 2P01-HL3970711, HD36457 (to C.W.L.), and HL36059 (to C.W.L.); National Science Foundation Grant IBN-9905067 (to C.W.L.); and American Heart Association Grant 003056T (to G.E.M.).
Footnotes
Original received January 24, 2001; revision received April 5, 2001; accepted April 5, 2001.
References
1. Yeager M. Structure of cardiac gap junction intercellular channels. J Struct Biol. 1998;121:231245.
2. van Kempen MJ, Vermeulen JL, Moorman AF, Gros D, Paul DL, Lamers WH. Developmental changes of connexin40 and connexin43 mRNA distribution patterns in the rat heart. Cardiovasc Res. 1996;32:886900.
3. Delorme B, Dahl E, Jarry-Guichard T, Marics I, Briand JP, Willecke K, Gros D, Theveniau-Ruissy M. Developmental regulation of connexin 40 gene expression in mouse heart correlates with the differentiation of the conduction system. Dev Dyn. 1995;204:358371.
4. Delorme B, Dahl E, Jarry-Guichard T, Briand JP, Willecke K, Gros D, Theveniau-Ruissy M. Expression pattern of connexin gene products at the early developmental stages of the mouse cardiovascular system. Circ Res. 1997;81:423437.
5. Chen SC, Davis LM, Westphale EM, Beyer EC, Saffitz JE. Expression of multiple gap junction proteins in human fetal and infant hearts. Pediatr Res. 1994;36:561566.
6. Dahl E, Winterhager E, Traub O, Willecke K. Expression of gap junction genes, connexin40 and connexin43, during fetal mouse development. Anat Embryol. 1995;191:267278.
7.
Coppen SR, Severs
NJ, Gourdie RG. Connexin45 (
6) expression delineates an extended
conduction system in the embryonic and mature rodent heart.
Dev Gen. 1999;24:8290.
8. Anumonwo JM, Wang HZ, Trabka-Janik E, Dunham B, Veenstra RD, Delmar M, Jalife J. Gap junctional channels in adult mammalian sinus nodal cells: immunolocalization and electrophysiology. Circ Res. 1992;71:229239.
9. Davis LM, Rodefeld ME, Green K, Beyer EC, Saffitz JE. Gap junction protein phenotypes of the human heart and conduction system. J Cardiovasc Electrophysiol. 1995;6:813822.
10. Kanter HL, Laing JG, Beyer EC, Green KG, Saffitz JE. Multiple connexins colocalize in canine ventricular myocyte gap junctions. Circ Res. 1993;73:344350.
11. Davis LM, Kanter HL, Beyer EC, Saffitz JE. Distinct gap junction protein phenotypes in cardiac tissues with disparate conduction properties. J Am Coll Cardiol. 1994;24:11241132.
12. Gourdie RG, Severs NJ, Green CR, Rothery S, Germroth P, Thompson RP. The spatial distribution and relative abundance of gap-junctional connexin40 and connexin43 correlate to functional properties of components of the cardiac atrioventricular conduction system. J Cell Sci. 1993;105:985991.
13. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, Rossant J. Cardiac malformation in neonatal mice lacking connexin43. Science. 1995;267:18311834.
14. Simon AM, Goodenough DA, Paul DL. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr Biol. 1998;8:295298.
15. Kirchhoff S, Nelles E, Hagendorff A, Kruger O, Traub O, Willecke K. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr Biol. 1998;8:299302.
16. Kumai M, Nishii K, Nakamura K, Takeda N, Suzuki M, Shibata Y. Loss of connexin45 causes a cushion defect in early cardiogenesis. Development. 2000;127:35013512.
17. Kruger O, Plum A, Kim J, Winterhager E, Maxeiner S, Hallas G, Kirchhoff S, Traub O, Lamers WH, Willecke K. Defective vascular development in connexin 45-deficient mice. Development. 2000;127:41794193.
18. Davies TC, Barr KJ, Jones DH, Zhu D, Kidder GM. Multiple members of the connexin gene family participate in preimplantation development of the mouse. Dev Genet. 1996;18:234243.
19. Ya J, Erdtsieck-Ernste EB, de Boer PA, van Kempen MJ, Jongsma H, Gros D, Moorman AF, Lamers WH. Heart defects in connexin43-deficient mice. Circ Res. 1998;82:360366.
20. Fromaget C, el Aoumari A, Dupont E, Briand JP, Gros D. Changes in the expression of connexin 43, a cardiac gap junctional protein, during mouse heart development. J Mol Cell Cardiol. 1990;22:12451258.
21. Davidenko JM, Pertsov AV, Salomonsz R, Baxter W, Jalife J. Stationary and drifting spiral waves of excitation in isolated cardiac muscle. Nature. 1992;355:349351.
22. Salama G, Kanai AJ, Huang D, Efimov IR, Girouard SD, Rosenbaum DS. Hypoxia and hypothermia enhance spatial heterogeneities of repolarization in guinea pig hearts: analysis of spatial autocorrelation of optically recorded action potential durations. J Cardiovasc Electrophysiol. 1998;9:164183.
23. Kwaku KF, Dillon SM. Shock-induced depolarization of refractory myocardium prevents wave-front propagation in defibrillation. Circ Res. 1996;79:957973.
24. Morley GE, Vaidya D, Samie FH, Lo CW, Delmar M, Jalife J. Characterization of conduction in the ventricles of normal and heterozygous connexin43 knockout mice using optical mapping. J Cardiovasc Electrophysiol. 1999;10:13611375.
25. Witkowski FX, Clark RB, Larsen TS, Melnikov A, Giles WR. Voltage-sensitive dye recordings of electrophysiological activation in a Langendorff-perfused mouse heart. Can J Cardiol. 1997;13:10771082.
26. Kamino K. Optical approaches to ontogeny of electrical activity and related functional organization during early heart development. Physiol Rev. 1991;71:5391.
27. Chuck ET, Freeman DM, Watanabe M, Rosenbaum DS. Changing activation sequence in the embryonic chick heart: implications for the development of the His-Purkinje system. Circ Res. 1997;81:470476.
28. Fast VG, Darrow BJ, Saffitz JE, Kleber AG. Anisotropic activation spread in heart cell monolayers assessed by high-resolution optical mapping: role of tissue discontinuities. Circ Res. 1996;79:115127.
29. Windisch H, Ahammer H, Schaffer P, Muller W, Platzer D. Optical multisite monitoring of cell excitation phenomena in isolated cardiomyocytes. Pflügers Arch. 1995;430:508518.
30. Tamaddon HS, Vaidya D, Simon AM, Paul DL, Jalife J, Morley GE. High-resolution optical mapping of the right bundle branch in connexin40 knockout mice reveals slow conduction in the specialized conduction system. Circ Res. 2000;87:929936.
31. Vaidya D, Morley GE, Samie FH, Jalife J. Reentry and fibrillation in the mouse heart: a challenge to the critical mass hypothesis. Circ Res. 1999;85:174181.
32. Keller BB, MacLennan MJ, Tinney JP, Yoshigi M. In vivo assessment of embryonic cardiovascular dimensions and function in day-10.5 to -14.5 mouse embryos. Circ Res. 1996;79:247255.
33. Srinivasan S, Baldwin HS, Aristizabal O, Kwee L, Labow M, Artman M, Turnbull DH. Noninvasive, in utero imaging of mouse embryonic heart development with 40-MHz echocardiography. Circulation. 1998;98:912918.
34. Wildenthal K. Maturation of responsiveness to cardioactive drugs: differential effects of acetylcholine, norepinephrine, theophylline, tyramine, glucagon, and dibutyryl cyclic AMP on atrial rate in hearts of fetal mice. J Clin Invest. 1973;52:22502258.
35. Grupp IL, Subramaniam A, Hewett TE, Robbins J, Grupp G. Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations. Am J Physiol. 1993;265:H1401H1410.
36. Kaufman MH. The Atlas of Mouse Development. San Diego, Calif: Academic Press; 1998.
37. Girouard SD, Laurita KR, Rosenbaum DS. Unique properties of cardiac action potentials recorded with voltage-sensitive dyes. J Cardiovasc Electrophysiol. 1996;7:10241038.
38. Pertsov AM, Davidenko JM, Salomonsz R, Baxter WT, Jalife J. Spiral waves of excitation underlie reentrant activity in isolated cardiac muscle. Circ Res. 1993;72:631650.
39. Wang L, Swirp S, Duff H. Age-dependent response of the electrocardiogram to K(+) channel blockers in mice. Am J Physiol. 2000;278:C73C80.
40. Johnson CM, Green KG, Kanter EM, Bou-Abboud E, Saffitz JE, Yamada KA. Voltage-gated Na+ channel activity and connexin expression in Cx43-deficient cardiac myocytes. J Cardiovasc Electrophysiol. 1999;10:13901401.
41. Rudy Y, Quan WL. A model study of the effects of the discrete cellular structure on electrical propagation in cardiac tissue. Circ Res. 1987;61:815823.
42. Alcolea S, Theveniau-Ruissy M, Jarry-Guichard T, Marics I, Tzouanacou E, Chauvin JP, Briand JP, Moorman A, Lamers WH, Gros DB. Downregulation of connexin 45 gene products during mouse heart development. Circ Res. 1999;84:13651379.
43. Plum A, Hallas G, Magin T, Dombrowski F, Hagendorff A, Schumacher B, Wolpert C, Kim J, Lamers WH, Evert M, Meda P, Traub O, Willecke K. Unique and shared functions of different connexins in mice. Curr Biol. 2000;10:10831091.
44. Keener JP, Panfilov AV. Three dimensional propagation in the heart: the effects of geometry and fiber orientation on propagation in myocardium. In: Zipes DP, Jalife J, eds. Cardiac Physiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders; 1995:335347.
45. Davies MP, An RH, Doevendans P, Kubalak S, Chien KR, Kass RS. Developmental changes in ionic channel activity in the embryonic murine heart. Circ Res. 1996;78:1525.
46. Wang L, Duff HJ. Developmental changes in transient outward current in mouse ventricle. Circ Res. 1997;81:120127.
47. Wang L, Duff HJ. Identification and characteristics of delayed rectifier K+ current in fetal mouse ventricular myocytes. Am J Physiol. 1996;270:H2088H2093.
48. Zhuang J, Yamada KA, Saffitz JE, Kleber AG. Pulsatile stretch remodels cell-to-cell communication in cultured myocytes. Circ Res. 2000;87:316322.
49. Guerrero PA, Schuessler RB, Davis LM, Beyer EC, Johnson CM, Yamada KA, Saffitz JE. Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J Clin Invest. 1997;99:19911998.
50. Thomas SA, Schuessler RB, Berul CI, Beardslee MA, Beyer EC, Mendelsohn ME, Saffitz JE. Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: evidence for chamber-specific molecular determinants of conduction. Circulation. 1998;97:686691.
51. Jongsma HJ, Wilders R. Gap junctions in cardiovascular disease. Circ Res. 2000;86:11931197.
52. Shaw RM, Rudy Y. Ionic mechanisms of propagation in cardiac tissue: roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ Res. 1997;81:727741.
This article has been cited by other articles:
![]() |
S. B. Danik, G. Rosner, J. Lader, D. E. Gutstein, G. I. Fishman, and G. E. Morley Electrical remodeling contributes to complex tachyarrhythmias in connexin43-deficient mouse hearts FASEB J, April 1, 2008; 22(4): 1204 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Beauchamp, K. A. Yamada, A. J. Baertschi, K. Green, E. M. Kanter, J. E. Saffitz, and A. G. Kleber Relative Contributions of Connexins 40 and 43 to Atrial Impulse Propagation in Synthetic Strands of Neonatal and Fetal Murine Cardiomyocytes Circ. Res., November 24, 2006; 99(11): 1216 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sedmera, A. Wessels, T. C. Trusk, R. P. Thompson, K. W. Hewett, and R. G. Gourdie Changes in activation sequence of embryonic chick atria correlate with developing myocardial architecture Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1646 - H1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ozawa, Y. K. Hayashi, M. Ogawa, R. Kurokawa, H. Matsumoto, S. Noguchi, I. Nonaka, and I. Nishino Emerin-Lacking Mice Show Minimal Motor and Cardiac Dysfunctions with Nuclear-Associated Vacuoles Am. J. Pathol., March 1, 2006; 168(3): 907 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bagwe, O. Berenfeld, D. Vaidya, G. E. Morley, and J. Jalife Altered Right Atrial Excitation and Propagation in Connexin40 Knockout Mice Circulation, October 11, 2005; 112(15): 2245 - 2253. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zeevi-Levin, Y. D. Barac, Y. Reisner, I. Reiter, G. Yaniv, G. Meiry, Z. Abassi, S. Kostin, J. Schaper, M. R. Rosen, et al. Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes Cardiovasc Res, April 1, 2005; 66(1): 64 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Beauchamp, C. Choby, T. Desplantez, K. de Peyer, K. Green, K. A. Yamada, R. Weingart, J. E. Saffitz, and A. G. Kleber Electrical Propagation in Synthetic Ventricular Myocyte Strands From Germline Connexin43 Knockout Mice Circ. Res., July 23, 2004; 95(2): 170 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Efimov, V. P. Nikolski, and G. Salama Optical Imaging of the Heart Circ. Res., July 9, 2004; 95(1): 21 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Dhamoon, S. V. Pandit, F. Sarmast, K. R. Parisian, P. Guha, Y. Li, S. Bagwe, S. M. Taffet, and J. M.B. Anumonwo Unique Kir2.x Properties Determine Regional and Species Differences in the Cardiac Inward Rectifier K+ Current Circ. Res., May 28, 2004; 94(10): 1332 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gros, L. Dupays, S. Alcolea, S. Meysen, L. Miquerol, and M. Theveniau-Ruissy Genetically modified mice: tools to decode the functions of connexins in the heart--new models for cardiovascular research Cardiovasc Res, May 1, 2004; 62(2): 299 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rohr Role of gap junctions in the propagation of the cardiac action potential Cardiovasc Res, May 1, 2004; 62(2): 309 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Thomas, J. P. Kucera, L. Bircher-Lehmann, Y. Rudy, J. E. Saffitz, and A. G. Kleber Impulse Propagation in Synthetic Strands of Neonatal Cardiac Myocytes With Genetically Reduced Levels of Connexin43 Circ. Res., June 13, 2003; 92(11): 1209 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Kucera, S. Rohr, and Y. Rudy Localization of Sodium Channels in Intercalated Disks Modulates Cardiac Conduction Circ. Res., December 13, 2002; 91(12): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sperelakis An Electric Field Mechanism for Transmission of Excitation Between Myocardial Cells Circ. Res., November 29, 2002; 91(11): 985 - 987. [Full Text] [PDF] |
||||
![]() |
R. J. Barker and R. G. Gourdie JNK Bond Regulation: Why Do Mammalian Hearts Invest in Connexin43? Circ. Res., October 4, 2002; 91(7): 556 - 558. [Full Text] [PDF] |
||||
![]() |
S. Rentschler, J. Zander, K. Meyers, D. France, R. Levine, G. Porter, S. A. Rivkees, G. E. Morley, and G. I. Fishman Neuregulin-1 promotes formation of the murine cardiac conduction system PNAS, August 6, 2002; 99(16): 10464 - 10469. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schram, M. Pourrier, P. Melnyk, and S. Nattel Differential Distribution of Cardiac Ion Channel Expression as a Basis for Regional Specialization in Electrical Function Circ. Res., May 17, 2002; 90(9): 939 - 950. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |